Testing effectiveness (Phase 2)Study completedNCT02250105
What this trial is testing
Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) Hypertriglyceridemia
Who this might be right for
Hypertriglyceridemia
Arisaph Pharmaceuticals Inc 80